Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02675569




Registration number
NCT02675569
Ethics application status
Date submitted
26/01/2016
Date registered
5/02/2016

Titles & IDs
Public title
ACCESS HD: Comparing Catheters to Fistulas in Elderly Patients Starting Hemodialysis
Scientific title
ACCESS HD Pilot: A Randomized Trial Comparing Catheters to Fistulas in Elderly patientS Starting HemoDialysis
Secondary ID [1] 0 0
REB14-1670
Universal Trial Number (UTN)
Trial acronym
ACCESS HD
Linked study record

Health condition
Health condition(s) or problem(s) studied:
End-stage Kidney Failure 0 0
Condition category
Condition code
Renal and Urogenital 0 0 0 0
Kidney disease
Other 0 0 0 0
Research that is not of generic health relevance and not applicable to specific health categories listed above

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Surgery - Catheter
Treatment: Surgery - Fistula

Active comparator: Catheter - Catheter is a method of vascular access for hemodialysis. It consists of a long, thin plastic tube and may be either tunnelled or non-tunnelled.

Experimental: Fistula - Fistula is a type of vascular access strategy for hemodialysis in which a direct connection of an artery to a vein is created. It is intended to provide an access with good blood flow that can last for decades.


Treatment: Surgery: Catheter
A method of vascular access for hemodialysis that all participants will have in place prior to randomization.

Treatment: Surgery: Fistula
A type of vascular access strategy for hemodialysis which involves connecting the artery and the veins in the participant's arm.
Intervention code [1] 0 0
Treatment: Surgery
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Feasibility; proportion of eligible people who are randomized (at least 25%)
Timepoint [1] 0 0
42 months
Primary outcome [2] 0 0
Feasibility; proportion of those randomized to the intervention arm receiving a fistula attempt within 90 days of randomization (at least 80%)
Timepoint [2] 0 0
42 months
Secondary outcome [1] 0 0
Descriptive; reasons for exclusion of all screened participants (feasibility)
Timepoint [1] 0 0
42 months
Secondary outcome [2] 0 0
Descriptive; reasons that people decline to participate (feasibility)
Timepoint [2] 0 0
42 months
Secondary outcome [3] 0 0
Descriptive; reasons people are considered ineligible for a fistula attempt (feasibility)
Timepoint [3] 0 0
42 months
Secondary outcome [4] 0 0
Descriptive; reasons for delayed access to fistula surgery (feasibility)
Timepoint [4] 0 0
42 months
Secondary outcome [5] 0 0
Safety; expected procedure-related outcomes for both catheter and fistula treatment strategies that occur within 7 days of the execution of any access related intervention
Timepoint [5] 0 0
7 days
Secondary outcome [6] 0 0
Number of drop-ins
Timepoint [6] 0 0
42 months
Secondary outcome [7] 0 0
Number of drop-outs
Timepoint [7] 0 0
42 months

Eligibility
Key inclusion criteria
1. Adult patients age = 55; (AUS sites : adult patients age = 65);
2. a). Started hemodialysis using a tunnelled, or non-tunnelled catheter for vascular access AND = 1 previously unsuccessful fistula attempt; OR b).Changing over from peritoneal dialysis AND no functioning arteriovenous fistula available at HD start;
3. Treated with hemodialysis for 365 days or less at the time of consent (374 days or less at the time of randomization);
4. Clinically and cognitively stable (able to provide consent within 365 days of hemodialysis start);
5. Hemodialysis is the intended modality of treatment;
6. End-stage (permanent) kidney failure unlikely to recover kidney function according to the attending nephrologist;
7. Eligible for a fistula attempt as determined by the local multidisciplinary access team;
8. Planning to remain in the current dialysis center/service for at least 6 months;
Minimum age
55 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Started hemodialysis with a fistula or have a patent fistula already in place or had >1 unsuccessful attempt; (AUS sites: or previously functioning fistula no longer working);
2. . Has had a prior arteriovenous graft creation;
3. Imminent transplant planned (within 6 months);
4. Metastatic malignancy or other condition associated with a life expectancy of less than 6 months, in the opinion of the attending nephrologist;

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/05/2016
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/03/2025
Actual
Sample size
Target
100
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,QLD
Recruitment hospital [1] 0 0
The Canberra Hospital - Garran
Recruitment hospital [2] 0 0
Illawarra Shoalhaven Local Health District (ISLHD) - Wollongong
Recruitment hospital [3] 0 0
Sunshine Coast Hospital and Health Service (SCHHS) - Birtinya
Recruitment postcode(s) [1] 0 0
2605 - Garran
Recruitment postcode(s) [2] 0 0
2500 - Wollongong
Recruitment postcode(s) [3] 0 0
4575 - Birtinya
Recruitment outside Australia
Country [1] 0 0
Canada
State/province [1] 0 0
Alberta
Country [2] 0 0
Canada
State/province [2] 0 0
Manitoba
Country [3] 0 0
Canada
State/province [3] 0 0
Newfoundland and Labrador
Country [4] 0 0
Canada
State/province [4] 0 0
Ontario

Funding & Sponsors
Primary sponsor type
Other
Name
University of Calgary
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
Applied Health Research Centre
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
The George Institute
Address [2] 0 0
Country [2] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Rob Quinn, PhD
Address 0 0
University of Calgary
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Sorcha Mulligan
Address 0 0
Country 0 0
Phone 0 0
416-360-4000
Fax 0 0
Email 0 0
sorcha.mulligan@unityhealth.to
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT02675569